NASDAQ:MBOTMicrobot Medical Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Microbot Medical Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $5.54 -0.10 (-1.77 %) (As of 04/9/2020 03:08 PM ET) Add Compare Share Today's Range$5.40Now: $5.54▼$5.7650-Day Range$4.42MA: $6.98▼$10.8152-Week Range$4.30Now: $5.54▼$20.15Volume4,039 shsAverage Volume158,101 shsMarket Capitalization$34.79 millionP/E RatioN/ADividend YieldN/ABeta4.75 ProfileAnalyst RatingsAdvanced ChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media Microbot Medical Inc., a pre-clinical medical device company, researches, designs, and develops micro-robotics assisted medical technologies targeting the minimally invasive surgery space. The company, through its ViRob and TipCAT micro-robotic technologies, is developing two product candidates, including the Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; and a self-propelling, semi-disposable endoscope, which is used in colonoscopy procedures. It also holds an intellectual property portfolio that comprises 9 patent families, which include 9 patents granted in the United States, 12 patents granted outside the United States, and 15 patent applications pending worldwide. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts.Read More Beat the Market (BTM) Rank™ 3.5 Analyst's Opinion Consensus RatingMicrobot Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $26.00, Microbot Medical has a potential upside of 369.3% from its current price of $5.54.Amount of Analyst CoverageMicrobot Medical has only been the subject of 1 research reports in the past 90 days. Previous Next 2.8 Community Rank Outperform VotesMicrobot Medical has received 339 “outperform” votes. (Add your “outperform” vote.)Underperform VotesMicrobot Medical has received 265 “underperform” votes. (Add your “underperform” vote.)Community SentimentMicrobot Medical has received 56.13% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Microbot Medical and other stocks. Vote “Outperform” if you believe MBOT will outperform the S&P 500 over the long term. Vote “Underperform” if you believe MBOT will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldMicrobot Medical does not currently pay a dividend.Dividend GrowthMicrobot Medical does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Microbot Medical insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 14.47% of the stock of Microbot Medical is held by insiders.Percentage Held by InstitutionsOnly 10.25% of the stock of Microbot Medical is held by institutions. Previous Next 0.0 Earnings and Valuation Earnings GrowthEarnings for Microbot Medical are expected to decrease by -35.90% in the coming year, from ($1.56) to ($1.00) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Microbot Medical is -2.77, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Microbot Medical is -2.77, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioMicrobot Medical has a P/B Ratio of 13.85. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 3.5Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.26 out of 5 stars Industry, Sector and Symbol Stock Exchange NASDAQ Industry Biological products, except diagnostic Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:MBOT Previous Symbol CUSIPN/A CIK883975 Webhttp://www.microbotmedical.com/ Phone781-875-3605Debt Debt-to-Equity Ratio0.02 Current Ratio2.29 Quick Ratio2.29Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$0.40 per share Price / Book13.85Profitability EPS (Most Recent Fiscal Year)($2.41) Net Income$-7,240,000.00 Net MarginsN/A Return on Equity-120.41% Return on Assets-68.71%Miscellaneous Employees9 Outstanding Shares6,280,000Market Cap$34.79 million Next Earnings Date5/20/2020 (Estimated) OptionableNot Optionable Receive MBOT News and Ratings via Email Sign-up to receive the latest news and ratings for MBOT and its competitors with MarketBeat's FREE daily newsletter. NASDAQ:MBOT Rates by TradingView Microbot Medical (NASDAQ:MBOT) Frequently Asked Questions How has Microbot Medical's stock been impacted by COVID-19 (Coronavirus)? Microbot Medical's stock was trading at $6.38 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, MBOT stock has decreased by 13.2% and is now trading at $5.54. View which stocks have been most impacted by Coronavirus. Do Wall Street analysts recommend investors buy shares of Microbot Medical? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Microbot Medical in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Microbot Medical. When is Microbot Medical's next earnings date? Microbot Medical is scheduled to release its next quarterly earnings announcement on Wednesday, May 20th 2020. View our earnings forecast for Microbot Medical. How were Microbot Medical's earnings last quarter? Microbot Medical Inc (NASDAQ:MBOT) announced its earnings results on Wednesday, November, 14th. The biotechnology company reported ($0.58) earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of ($0.60) by $0.02. View Microbot Medical's earnings history. When did Microbot Medical's stock split? How did Microbot Medical's stock split work? Microbot Medical shares reverse split on Monday, May 9th 2016. The 1-12 reverse split was announced on Friday, May 6th 2016. The number of shares owned by shareholders was adjusted after the market closes on Friday, May 6th 2016. An investor that had 100 shares of Microbot Medical stock prior to the reverse split would have 8 shares after the split. What price target have analysts set for MBOT? 1 analysts have issued twelve-month target prices for Microbot Medical's stock. Their forecasts range from $26.00 to $26.00. On average, they expect Microbot Medical's stock price to reach $26.00 in the next twelve months. This suggests a possible upside of 369.3% from the stock's current price. View analysts' price targets for Microbot Medical. What are Wall Street analysts saying about Microbot Medical stock? Here are some recent quotes from research analysts about Microbot Medical stock: 1. According to Zacks Investment Research, "Microbot Medical Inc. is engaged in the research, design, development and commercialization of micro-robotics assisted medical technologies. Its product candidate includes the Self Cleaning Shunt for the treatment of hydrocephalus and Normal Pressure Hydrocephalus and TipCAT, a self-propelling, semi-disposable endoscope which is being developed initially for use in colonoscopy procedures. Microbot Medical Inc., formerly known as Stemcells, Inc., is headquartered in Hingham, MA. " (3/17/2020) 2. HC Wainwright analysts commented, "Our price target is derived from an estimated market value of the firm at $60M, which includes a discounted cash flow (DCF)-based asset value of SCS, assuming 60% probability of approval, 20% discount rate and 2% terminal growth rate." (9/11/2019) Has Microbot Medical been receiving favorable news coverage? News stories about MBOT stock have trended very negative this week, according to InfoTrie Sentiment Analysis. InfoTrie rates the sentiment of news coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Microbot Medical earned a daily sentiment score of -3.3 on InfoTrie's scale. They also assigned headlines about the biotechnology company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the near term. View the latest news aboutMicrobot Medical. Who are some of Microbot Medical's key competitors? Some companies that are related to Microbot Medical include Windtree Therapeutics (WINT), Verona Pharma (TARA), Brainstorm Cell Therapeutics (BCLI), Fennec Pharmaceuticals (FENC), Vaxart (VXRT), Solid Biosciences (SLDB), LogicBio Therapeutics (LOGC), Cidara Therapeutics (CDTX), Erytech Pharma (ERYP), Champions Oncology (CSBR), Gamida Cell (GMDA), Axcella Health (AXLA), Pluristem Therapeutics (PSTI), AIM ImmunoTech (AIM) and Neon Therapeutics (NTGN). What other stocks do shareholders of Microbot Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Microbot Medical investors own include TransEnterix (TRXC), Advanced Micro Devices (AMD), Novavax (NVAX), Gilead Sciences (GILD), NVIDIA (NVDA), Athersys (ATHX), Micron Technology (MU), Sarepta Therapeutics (SRPT), NovaBay Pharmaceuticals (NBY) and Inovio Pharmaceuticals (INO). Who are Microbot Medical's key executives? Microbot Medical's management team includes the following people: Mr. Harel Gadot, Co-Founder, Pres, CEO & Chairman (Age 46)Mr. David Ben Naim CPA, M.B.A., Chief Financial Officer (Age 50)Dr. Simon Sharon, CTO & Chairman of Scientific Advisory BoardProf. Moshe Shoham, Co-Founder, Scientific Director & Member of Scientific Advisory Board (Age 67)Dr. Eric C. Leuthardt, Scientific Director & Member of Scientific Advisory Board What is Microbot Medical's stock symbol? Microbot Medical trades on the NASDAQ under the ticker symbol "MBOT." How do I buy shares of Microbot Medical? Shares of MBOT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Microbot Medical's stock price today? One share of MBOT stock can currently be purchased for approximately $5.54. How big of a company is Microbot Medical? Microbot Medical has a market capitalization of $34.79 million. The biotechnology company earns $-7,240,000.00 in net income (profit) each year or ($2.41) on an earnings per share basis. Microbot Medical employs 9 workers across the globe. View additional information about Microbot Medical. What is Microbot Medical's official website? The official website for Microbot Medical is http://www.microbotmedical.com/. How can I contact Microbot Medical? Microbot Medical's mailing address is 25 RECREATION PARK DRIVE UNIT 108, HINGHAM MA, 02043. The biotechnology company can be reached via phone at 781-875-3605 or via email at [email protected] This page was last updated on 4/9/2020 by MarketBeat.com StaffFeatured Article: Pattern Day Trader - What is the PDT Rule?
